Brain scans reveal how a new pill might quiet cigarette cravings
NCT ID NCT06617312
First seen Dec 12, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tests whether the drug cytisinicline can change how the brain reacts to seeing smoking-related images. 64 daily smokers who are not trying to quit will receive either the drug or a placebo and undergo brain scans. The goal is to see if the drug reduces brain activity linked to cigarette cravings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Los Angeles
RECRUITINGLos Angeles, California, 90049, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.